First Time Loading...

BioCardia Inc
NASDAQ:BCDA

Watchlist Manager
BioCardia Inc Logo
BioCardia Inc
NASDAQ:BCDA
Watchlist
Price: 0.3799 USD 1.31% Market Closed
Updated: May 6, 2024

BioCardia Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioCardia Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
BioCardia Inc
NASDAQ:BCDA
Revenue
$477k
CAGR 3-Years
47%
CAGR 5-Years
-5%
CAGR 10-Years
6%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

See Also

What is BioCardia Inc's Revenue?
Revenue
477k USD

Based on the financial report for Dec 31, 2023, BioCardia Inc's Revenue amounts to 477k USD.

What is BioCardia Inc's Revenue growth rate?
Revenue CAGR 10Y
6%

Over the last year, the Revenue growth was -65%. The average annual Revenue growth rates for BioCardia Inc have been 47% over the past three years , -5% over the past five years , and 6% over the past ten years .